BSE Live
Sep 05, 16:01Prev. Close
248.20
Open Price
257.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
Key Financial Ratios of Trident Texofab (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 2.38 | 1.07 | 2.20 | 0.98 | 0.35 | |
Diluted EPS (Rs.) | 2.09 | 1.07 | 2.20 | 0.98 | 0.35 | |
Cash EPS (Rs.) | 3.07 | 2.71 | 3.84 | 2.43 | 1.37 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 34.84 | 16.14 | 15.07 | 12.87 | 11.89 | |
Book Value [InclRevalReserve]/Share (Rs.) | 34.84 | 16.14 | 15.07 | 12.87 | 11.89 | |
Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 90.02 | 98.79 | 95.69 | 83.71 | 49.58 | |
PBDIT/Share (Rs.) | 6.47 | 6.50 | 8.15 | 5.49 | 4.70 | |
PBIT/Share (Rs.) | 5.26 | 4.86 | 6.52 | 4.03 | 3.69 | |
PBT/Share (Rs.) | 1.90 | 1.16 | 2.71 | 1.26 | 0.90 | |
Net Profit/Share (Rs.) | 1.85 | 1.07 | 2.20 | 0.98 | 0.35 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 7.18 | 6.57 | 8.52 | 6.55 | 9.48 | |
PBIT Margin (%) | 5.83 | 4.92 | 6.81 | 4.81 | 7.43 | |
PBT Margin (%) | 2.11 | 1.17 | 2.82 | 1.51 | 1.81 | |
Net Profit Margin (%) | 2.05 | 1.08 | 2.30 | 1.16 | 0.70 | |
Return on Networth / Equity (%) | 5.31 | 6.64 | 14.61 | 7.58 | 2.94 | |
Return on Capital Employed (%) | 11.91 | 12.35 | 16.38 | 9.96 | 9.89 | |
Return on Assets (%) | 2.49 | 1.31 | 2.86 | 1.38 | 0.52 | |
Total Debt/Equity (X) | 0.56 | 2.27 | 2.28 | 2.78 | 2.43 | |
Asset Turnover Ratio (%) | 1.34 | 1.25 | 1.30 | 1.21 | 0.81 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.81 | 1.23 | 1.25 | 1.32 | 1.32 | |
Quick Ratio (X) | 1.42 | 0.91 | 0.97 | 1.08 | 1.06 | |
Inventory Turnover Ratio (X) | 1.27 | 1.62 | 2.63 | 1.87 | 0.58 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 260.35 | 85.97 | 92.54 | 98.28 | 55.04 | |
EV/Net Operating Revenue (X) | 2.13 | 0.86 | 0.96 | 1.17 | 1.10 | |
EV/EBITDA (X) | 29.68 | 13.14 | 11.27 | 17.78 | 11.63 | |
MarketCap/Net Operating Revenue (X) | 1.94 | 0.49 | 0.60 | 0.74 | 0.52 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 5.02 | 3.02 | 3.82 | 4.81 | 2.17 | |
Price/Net Operating Revenue | 1.94 | 0.49 | 0.60 | 0.74 | 0.52 | |
Earnings Yield | 0.01 | 0.02 | 0.04 | 0.02 | 0.01 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017